These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38897703)

  • 1. Influence of obesity on blood glucose control using continuous glucose monitoring data among patients with type 1 diabetes.
    Nicolau J; Romano A; Rodríguez I; Sanchís P; Puga M; Masmiquel L
    Endocrinol Diabetes Nutr (Engl Ed); 2024 May; 71(5):202-207. PubMed ID: 38897703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes.
    Garg SK; Akturk HK; Kaur G; Beatson C; Snell-Bergeon J
    Diabetes Technol Ther; 2024 Jun; 26(6):367-374. PubMed ID: 38512447
    [No Abstract]   [Full Text] [Related]  

  • 3. Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?
    Flokas ME; Zeymo A; Mete M; Anhalt H; Rother KI; Gourgari E
    J Diabetes Complications; 2020 Apr; 34(4):107513. PubMed ID: 32007420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
    Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
    Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes.
    Garg SK; Kaur G; Haider Z; Rodriquez E; Beatson C; Snell-Bergeon J
    Diabetes Technol Ther; 2024 Mar; 26(3):184-189. PubMed ID: 38444317
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Maffeis C
    Pediatr Diabetes; 2022 Feb; 23(1):84-89. PubMed ID: 34888998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
    Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.
    Marbán-Castro E; Muhwava L; Kamau Y; Safary E; Rheeder P; Karsas M; Kemp T; Freitas J; Carrihill M; Dave J; Katambo D; Kimetto J; Allie R; ; ; Ndungu J; Sigwebela N; Akach D; Girdwood S; Erkosar B; Nichols BE; Haldane C; Vetter B; Shilton S
    Trials; 2024 May; 25(1):331. PubMed ID: 38773658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decade of improved glycemic control in young children with type 1 diabetes: A population-based cohort study.
    Sundberg F; Nåtman J; Franzen S; Åkesson K; Särnblad S
    Pediatr Diabetes; 2021 Aug; 22(5):742-748. PubMed ID: 33837985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).
    Rama Chandran S; Rahman N; Gandhi M; Tan NC; Phoon IKY; Seah DEJ; Cheah MH; Sek K; Gardner DS
    Diabetes Res Clin Pract; 2024 May; 211():111678. PubMed ID: 38642860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.